Blood donor screening for parvovirus B19 in Germany and Austria

Transfusion

Volumn 47, Issue 10, 2007, Pages 1775-1782

  Schmidt, Michael ^a   Themann, Anna ^b   Drexler, Camilla ^b   Bayer, Michaela ^b   Lanzer, Gerhard ^b   Menichetti, Eva ^b   Lechner, Sigrid ^b   Wessin, Dietmar ^b   Prokoph, Barbara ^b   Allain, Jean Pierre ^b   Seifried, Erhard ^b   Kai Hourfar, Michael ^b  

^a GOETHE UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PROTEIN VP2;

ADULT; ARTICLE; AUSTRIA; BLOOD DONOR; CLINICAL ARTICLE; CONTROLLED STUDY; DONOR SELECTION; ERYTHEMA INFECTIOSUM; FEMALE; GERMANY; HUMAN; INCIDENCE; INFECTION RISK; MALE; PARVOVIRUS; SCREENING; SENSITIVITY AND SPECIFICITY; VIRUS LOAD;

ADULT; AUSTRIA; BLOOD DONORS; CASE-CONTROL STUDIES; DNA, VIRAL; ERYTHEMA INFECTIOSUM; FEMALE; GERMANY; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PARVOVIRUS B19, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS; SENSITIVITY AND SPECIFICITY;

EID: 34548759116     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01443.x     Document Type: Article

References (32)

1. Cossart YE, Field AM, Cant B, Widdows D. Parvovirus-like particles in human sera. Lancet 1975 1 : 72 3.
2. Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004 350 : 586 97.
3. Chisaka H, Morita E, Yaegashi N, Sugamura K. Parvovirus B19 and the pathogenesis of anaemia. Rev Med Virol 2003 13 : 347 59.
4. Koppelman MH, Cuypers HT, Emrich T, Zaaijer HL. Quantitative real-time detection of parvovirus B19 DNA in plasma. Transfusion 2004 44 : 97 103.
5. Anderson LJ, Tsou C, Parker RA, Chorba TL, Wulff H, Tattersall P, Mortimer PP. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol 1986 24 : 522 6.
6. Prowse C, Ludlam CA, Yap PL. Human parvovirus B19 and blood products. Vox Sang 1997 72 : 1 10.
7. Enders M, Weidner A, Enders G. Current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of Germany. Epidemiol Infect 2007 135 : 563 9.
8. Pattison JR. Human parvovirus B19. BMJ 1994 308 : 149 50.
9. Heegaard ED, Hornsleth A. Parvovirus: the expanding spectrum of disease. Acta Paediatr 1995 84 : 109 17.
10. Hartman KR, Brown KE, Green SW, Young NS. Lack of evidence for parvovirus B19 viraemia in children with chronic neutropenia. Br J Haematol 1994 88 : 895 6.
11. Muir KW, Fitzsimons E. Human parvovirus infection and transient erythroblastopenia of childhood. Br J Haematol 1992 81 : 622.
12. Shirono K, Tsuda H. Parvovirus B19-associated haemophagocytic syndrome in healthy adults. Br J Haematol 1995 89 : 923 6.
13. Nagai K, Morohoshi T, Kudoh T, Yoto Y, Suzuki N, Matsunaga Y. Transient erythroblastopenia of childhood with megakaryocytopenia associated with human parvovirus B19 infection. Br J Haematol 1992 80 : 131 2.
14. Anderson MJ, Higgins PG, Davis LR, Willman JS, Jones SE, Kidd IM, Pattison JR, Tyrrell DA. Experimental parvoviral infection in humans. J Infect Dis 1985 152 : 257 65.
15. Kurtzman G, Frickhofen N, Kimball J, Jenkins DW, Nienhuis AW, Young NS. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med 1989 321 : 519 23.
16. Prospective study of human parvovirus (B19) infection in pregnancy. Public Health Laboratory Service Working Party on Fifth Disease. BMJ 1990 300 : 1166 70.
17. Roth WK, Seifried E. The German experience with NAT. Transfus Med 2002 12 : 255 8.
18. Roth WK, Buhr S, Drosten C, Seifried E. NAT and viral safety in blood transfusion. Vox Sang 2000 78 (Suppl 2 257 9.
19. Roth WK, Weber M, Seifried E. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting. Lancet 1999 353 : 359 63.
20. Candotti D, Danso K, Parsyan A, Dompreh A, Allain JP. Maternal-fetal transmission of human parvovirus B19 genotype 3. J Infect Dis 2006 194 : 608 11.
21. Parsyan A, Addo-Yobo E, Owusu-Ofori S, Akpene H, Sarkodie F, Allain JP. Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area. Transfusion 2006 46 : 1593 600.
22. Parsyan A, Kerr S, Owusu-Ofori S, Elliott G, Allain JP. Reactivity of genotype-specific recombinant proteins of human erythrovirus B19 with plasmas from areas where genotype 1 or 3 is endemic. J Clin Microbiol 2006 44 : 1367 75.
23. Hokynar K, Brunstein J, Soderlund-Venermo M, Kiviluoto O, Partio EK, Konttinen Y, Hedman K. Integrity and full coding sequence of B19 virus DNA persisting in human synovial tissue. J Gen Virol 2000 81 : 1017 25.
24. McOmish F, Yap PL, Jordan A, Cohen BJ, Simmonds P. Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction. J Clin Microbiol 1993 31 : 323 8.
25. Cohen BJ, Field AM, Gudnadottir S, Beard S, Barbara JA. Blood donor screening for parvovirus B19. J Virol Methods 1990 30 : 233 8.
26. Tsujimura M, Matsushita K, Shiraki H, Sato H, Okochi K, Maeda Y. Human parvovirus B19 infection in blood donors. Vox Sang 1995 69 : 206 12.
27. Kelly HA, Siebert D, Hammond R, Leydon J, Kiely P, Maskill W. The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world. Epidemiol Infect 2000 124 : 449 57.
28. Zaaijer HL, Koppelman MH, Farrington CP. Parvovirus B19 viraemia in Dutch blood donors. Epidemiol Infect 2004 132 : 1161 6.
29. Modrow S. Parvovirus B19: the causative agent of dilated cardiomyopathy or a harmless passenger of the human myocard? Ernst Schering Res Found Workshop 2006 55 : 63 82.
30. Manaresi E, Gallinella G, Morselli Labate AM, Zucchelli P, Zaccarelli D, Ambretti S, Delbarba S, Zerbini M, Musiani M. Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors. Epidemiol Infect 2004 132 : 857 62.
31. Manaresi E, Gallinella G, Venturoli S, Zerbini M, Musiani M. Detection of parvovirus B19 IgG: choice of antigens and serological tests. J Clin Virol 2004 29 : 51 3.
32. Cohen BJ, Buckley MM. The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 1988 25 : 151 3.